Integrative Peptides' best-selling product, BPC-157, contains 500mcg of the systemically active, multi-function peptide in a new peppermint-flavored oral spray format.*
GLP-1RAs have been shown to reduce blood pressure, although the exact mechanism is unknown
While complete reversal is challenging, early intervention with the right supplements, diet, and exercise program can significantly improve bone density and reduce fracture risk
Yang WS, Stockwell BR
A novel interaction of diethyldithiocarbamate with the glutathione/glutathione [PMID: 3019961] Laboratory literature summary: A novel interaction of diethyldithiocarbamate with the glutathione/glutathione peroxidase system
A 2021 phase 2 trial published in The New England Journal of Medicine showed semaglutide 2.4 mg achieved NASH resolution without worsening fibrosis in 59% of patients versus 17% on placebo (Newsome et al., NEJM 2021)